Buy or sell Medrobotics stock pre IPO via an EquityZen fund
Medrobotics Corporation is a medical robotics company developing and commercializing the Flex Robotic System.
About Medrobotics Stock
Medrobotics Corporation (formerly Cardioborobotics, Inc.) is a Delaware "C" Corporation, originally formed in 2005 (as Innovention Technologies, LLC) by the inventors of our technology. They are Howie Choset, PhD, a tenured Associate Professor of Robotics at Carnegie Mellon University, Dr. Marco Zenati, a cardiothoracic surgeon and Visiting Professor of Surgery at Harvard Medical School, and Dr. Alon Wolf, Associate Professor at Technion University in Israel. Dr. Zenati was on the medical faculty of the University of Pittsburgh at the time he and Drs. Choset and Wolf developed the first generation medical "snake robotics" platform in-licensed by the Company. Dr. Choset and Dr. Zenati continue to remain involved in technology development at the Company. Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility in New England, with partners located throughout the United States.
Vice President, Global Sales
Chief Financial Officer & Treasurer
Vice President, Clinical, Regulatory & Quality Affairs
Vice President, Intellectual Property Strategy
Chairman of the Board of Directors
Vice President of Operations
Vice President, Marketing
President & CEO